Vanguard Group
LUNG icon

Vanguard Group’s Pulmonx LUNG Stock Holding History

Vanguard Group’s Portfolio LUNG Stock Details LUNG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$5.61M Buy
2,540,535
+298,348
+13% +$561K ﹤0.01% 3208
2025
Q3 		$3.63M Sell
2,242,187
-51,801
-2% -$108K ﹤0.01% 3381
2025
Q2 		$5.94M Buy
2,293,988
+11,681
+0.5% +$46.1K ﹤0.01% 3150
2025
Q1 		$15.4M Sell
2,282,307
-1,152
-0.1% -$8.16K ﹤0.01% 2625
2024
Q4 		$15.5M Buy
2,283,459
+4,554
+0.2% +$30K ﹤0.01% 2716
2024
Q3 		$18.9M Buy
2,278,905
+103,292
+5% +$747K ﹤0.01% 2615
2024
Q2 		$13.8M Buy
2,175,613
+97,754
+5% +$752K ﹤0.01% 2745
2024
Q1 		$19.3M Buy
2,077,859
+11,417
+0.6% +$134K ﹤0.01% 2619
2023
Q4 		$26.3M Buy
2,066,442
+42,606
+2% +$444K ﹤0.01% 2473
2023
Q3 		$20.9M Buy
2,023,836
+19,364
+1% +$224K ﹤0.01% 2535
2023
Q2 		$26.3M Sell
2,004,472
-590,541
-23% -$7.22M ﹤0.01% 2476
2023
Q1 		$29M Buy
2,595,013
+175,393
+7% +$1.73M ﹤0.01% 2431
2022
Q4 		$20.4M Sell
2,419,620
-732,122
-23% -$6.96M ﹤0.01% 2620
2022
Q3 		$52.5M Buy
3,151,742
+18,232
+0.6% +$336K ﹤0.01% 2158
2022
Q2 		$46.1M Buy
3,133,510
+516,991
+20% +$10.7M ﹤0.01% 2235
2022
Q1 		$64.9M Buy
2,616,519
+92,031
+4% +$2.38M ﹤0.01% 2173
2021
Q4 		$81M Buy
2,524,488
+72,373
+3% +$2.64M ﹤0.01% 2094
2021
Q3 		$88.2M Buy
2,452,115
+563,840
+30% +$22.2M ﹤0.01% 2049
2021
Q2 		$83.3M Buy
1,888,275
+746,635
+65% +$32.5M ﹤0.01% 2091
2021
Q1 		$52.2M Buy
1,141,640
+42,881
+4% +$2.46M ﹤0.01% 2287
2020
Q4 		$75.8M Buy
+1,098,759
New +$53.8M ﹤0.01% 1978

Other funds holding LUNG

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
ECM
ExodusPoint Capital Management New York $12.6B AUM 30.13% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Vanguard Group's LUNG Position: Q4 2025 in Review

Vanguard Group increased its Pulmonx (LUNG) stake by 13% in Q4 2025, buying an estimated $561K and bringing the position to 2,540,535 shares worth $5.61M. The position accounts for ﹤0.01% of the portfolio, ranked #3208.

Vanguard Group first reported a position in LUNG in Q4 2020 and has held it in 21 quarters since. The position peaked at $88.2M in Q3 2021. 112 funds tracked by Wall St. Rank hold LUNG as of Q4 2025.

  • Vanguard Group held 2,540,535 shares of Pulmonx worth $5.61M as of Q4 2025.
  • Vanguard Group bought 298,348 Pulmonx shares in Q4 2025, an estimated $561K.
  • Pulmonx made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #3208 holding.
  • Vanguard Group first reported a position in Pulmonx in Q4 2020 and has held it in 21 quarters since.
  • Vanguard Group's Pulmonx position peaked at $88.2M in Q3 2021.
  • 112 funds tracked by Wall St. Rank held Pulmonx as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.